Key result
Systemic levels of omentin-1 were positively associated with increases in glycaemia and incident type 2 diabetes in older adults, independent of adiponectin.
Why the study?
Are baseline serum levels of omentin-1 and adiponectin associated with changes in glycaemia and incident type 2 diabetes in older adults?
Cohort (n=506)
Are baseline serum levels of omentin-1 and adiponectin associated with changes in glycaemia and incident type 2 diabetes in older adults?
Higher systemic levels of omentin-1 are independently associated with increased risk of incident type 2 diabetes and worsening glycaemia in older adults.
No takes yet. Share an insight, caveat, or question.
Omentin-1 should not yet inform diabetes risk assessment in older adults; leaves open causal or predictive utility beyond adiponectin.
Herder et al. (2017) conducted a cohort in Type 2 diabetes (n=506). Serum omentin-1 was evaluated on Changes in glycaemia and incident type 2 diabetes. Systemic levels of omentin-1 were positively associated with increases in glycaemia and incident type 2 diabetes in older adults, independent of adiponectin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: